CytomX Therapeutics, Inc. (CTMX)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 09:57AM EDT. Market open.
| Previous close | 1.6000 |
| Open | 1.5950 |
| Bid | 1.6000 x 200 |
| Ask | 1.6700 x 200 |
| Day's range | 1.5950 - 1.6500 |
| 52-week range | 1.0400 - 2.8550 |
| Volume | |
| Avg. volume | 929,246 |
| Market cap | 110.741M |
| Beta (5Y monthly) | 1.02 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Here's Why We're Not Too Worried About CytomX Therapeutics' (NASDAQ:CTMX) Cash Burn Situation
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
- Simply Wall St.
CytomX Therapeutics Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags
CytomX Therapeutics ( NASDAQ:CTMX ) Full Year 2023 Results Key Financial Results Revenue: US$101.2m (up 90% from FY...
- Insider Monkey
CytomX Therapeutics, Inc. (NASDAQ:CTMX) Q4 2023 Earnings Call Transcript
CytomX Therapeutics, Inc. (NASDAQ:CTMX) Q4 2023 Earnings Call Transcript March 11, 2024 CytomX Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and thank you for standing by. Welcome to the CytomX Therapeutics Fourth Quarter 2023 Financial […]
© 2024 Yahoo. All rights reserved.